More on ALXO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+65.3% Growth)
- Ratings (8.8 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ALX Oncology (NQ:ALXO)
Delayed: 2.10 +0.03 (1.45%)
Prev. Close $2.07  
Open$2.04 
52 Wk High$ 
52 Wk Low$ 
Day High$2.16 
Day Low$1.99 
P/E N/A  
EPS$ 
Volume765,313 

Friends, Peers and Foes (?): ERAS, IMRX, ONCY PRLD (more...)

Jul 6, 2026 04:31 PM Form 4 ALX ONCOLOGY HOLDINGS For: Jul 01 Filed by: Wong Shelly
Jun 30, 2026 04:40 PM ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
Jun 30, 2026 04:03 PM Corey Goodman resigns as ALX Oncology board chairman
Jun 30, 2026 04:01 PM Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 29
Jun 30, 2026 08:00 AM ALX Oncology names new board chairman and general counsel
Jun 30, 2026 08:00 AM ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
Jun 26, 2026 04:02 PM Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 25
Jun 11, 2026 04:02 PM Form 8-K ALX ONCOLOGY HOLDINGS For: Jun 10
Jun 1, 2026 08:00 AM ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
May 27, 2026 04:18 PM Form SCHEDULE 13D/A ALX ONCOLOGY HOLDINGS Filed by: LSV Associates, LLC
View All Articles

Entities mentioned with ALXO

View All Entities